Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 6,001–6,025 of 7,816 matching trials · page 241 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Imaging the Neural Network Connectivity on Patients With Mild Cognitive Impairment NCT01927653 Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 108 | Chang Gung Memorial Hospital OTHER |
2018-07-18 |
|
ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) NCT02319005 Revusiran (ALN-TTRSC); Sterile Normal Saline (0.9% NaCl) Runs in: Belgium; Canada; France; Germany; Italy; Spain; Sweden; U... · 61 sites |
PHASE3 other |
COMPLETED | 206 | Alnylam Pharmaceuticals INDUSTRY |
2018-07-18 |
|
Omega-3 Supplementation and Behavior Problems NCT02334098 Omega-3 supplemented drink; Smartfish Runs in: China · 1 site |
PHASE2|PHASE3 other |
COMPLETED | 324 | Dr. Annis Fung OTHER |
2018-07-18 |
|
Mind-Body Skills Groups for Behavioral and Emotional Problems in War-Traumatized Male Adolescents in Gaza NCT02671487 Mind-Body Skills Groups Runs in: Palestinian Territories · 1 site |
NA other |
COMPLETED | 115 | The Center for Mind-Body Medicine OTHER |
2018-07-18 |
|
Dementia Associated Apathy. NCT03293537 Skin conductance and Heart rate measurement Runs in: Switzerland · 1 site |
NA other |
UNKNOWN | 133 | Zurich University of Applied Sciences OTHER |
2018-07-16 |
|
Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB). NCT02448784 Donepezil Hydrochloride Runs in: Japan · 1 site |
NA symptomatic-cholinergic |
COMPLETED | 591 | Eisai Co., Ltd. INDUSTRY |
2018-07-11 |
|
AllyQuest: Engaging HIV+ YMSM in Care Through Social Networking and Gamification NCT03090958 AllyQuest |
NA other |
COMPLETED | 20 | University of North Carolina, Chapel Hill OTHER |
2018-07-11 |
|
Validation of the Montreal Cognitive Assessment in Patients With Mild and Major Neurocognitive Disorder NCT03581643 Runs in: Switzerland · 1 site |
NA other |
COMPLETED | 430 | Andreas Monsch OTHER |
2018-07-10 |
|
Olfactory Deficits in MCI as Predictor of Improved Cognition on Donepezil NCT01845636 Donepezil; Atropine Runs in: United States · 1 site |
PHASE4 symptomatic-cholinergic |
COMPLETED | 41 | New York State Psychiatric Institute OTHER |
2018-07-09 |
|
A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease NCT02431468 Bryostatin 1; Placebo Runs in: United States · 29 sites |
PHASE2 other |
COMPLETED | 147 | Neurotrope Bioscience, Inc. INDUSTRY |
2018-07-06 |
|
Gait Disorders in Patients With Cognitive Decline NCT03399591 Runs in: France · 1 site |
NA other |
UNKNOWN | 100 | University Hospital, Strasbourg, France OTHER |
2018-07-06 |
|
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease NCT00955422 Runs in: United States · 1 site |
NA other |
COMPLETED | 197 | National Institute of Mental Health (NIMH) NIH |
2018-07-05 |
|
Switching From Efavirenz/Atripla to Rilpivirine Among Patients With Neurocognitive or Neuropsychological Side Effects NCT02042001 Immediate switch to TDF/FTC/RPV; Switch to TDF/FTC/RPV after 24 weeks Runs in: Italy · 5 sites |
PHASE4 other |
COMPLETED | 74 | Azienda Ospedaliera San Gerardo di Monza OTHER |
2018-07-05 |
|
PET Imaging in Chronic Traumatic Encephalopathy NCT02211820 Runs in: United States · 1 site |
NA other |
COMPLETED | 6 | National Institute of Mental Health (NIMH) NIH |
2018-07-05 |
|
Health-eBrain Study NCT02903862 Mindoula; DANA Runs in: United States · 1 site |
NA other |
WITHDRAWN | 0 | AnthroTronix, Inc. INDUSTRY |
2018-07-03 |
|
A Non-drug Methods Study in Participants With Alzheimer's Disease NCT01459016 PET scan using florbetapir; MRI Scan Runs in: France · 16 sites |
PHASE1 other |
COMPLETED | 56 | Eli Lilly and Company INDUSTRY |
2018-06-28 |
|
Optimizing Prescribing of Antipsychotics in Long-Term Care NCT03557593 Educational |
NA other |
COMPLETED | — | Queen's University OTHER |
2018-06-26 |
|
Consequences of At-risk Alcohol Consumption in ICU Patients NCT03565016 no interventional study Runs in: France · 1 site |
NA other |
COMPLETED | 150 | Nantes University Hospital OTHER |
2018-06-21 |
|
Metabolic Effects of Antipsychotics in Children NCT00205699 risperidone; olanzapine; aripiprazole Runs in: United States · 1 site |
PHASE4 other |
COMPLETED | 144 | Washington University School of Medicine OTHER |
2018-06-15 |
|
Blood-Brain-Barrier Opening Using Focused Ultrasound With IV Contrast Agents in Patients With Early Alzheimer's Disease NCT02986932 BBB opening Runs in: Canada · 1 site |
NA other |
COMPLETED | 6 | InSightec INDUSTRY |
2018-06-14 |
|
Exercise Effects in Huntington's Disease NCT01879267 Exercise training Runs in: Switzerland · 1 site |
NA other |
COMPLETED | 40 | University of Zurich OTHER |
2018-06-13 |
|
Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder NCT02048241 Parent Management Training; Placebo; Intuniv Runs in: United States · 1 site |
PHASE4 other |
COMPLETED | 11 | New York State Psychiatric Institute OTHER |
2018-06-13 |
|
11C-PIB PET/CT in Patients With Parkinson's Disease and Parkinsonian Dementia Syndromes NCT03555292 11C-PiB Runs in: China · 3 sites |
PHASE2 other |
UNKNOWN | 200 | Oriental Neurosurgery Evidence-Based-Study Team OTHER |
2018-06-13 |
|
Apathy in Dementia Methylphenidate Trial (ADMET) NCT01117181 Methylphenidate; placebo; Psychosocial intervention Runs in: Canada; United States · 3 sites |
PHASE2 other |
COMPLETED | 60 | Johns Hopkins Bloomberg School of Public Health OTHER |
2018-06-12 |
|
Good Rate of Clinical Response to Cholinesterase Inhibitors in Alzheimer's Disease After Three Months of Treatment NCT02007291 |
NA symptomatic-cholinergic |
COMPLETED | 71 | Federal University of Minas Gerais OTHER |
2018-06-12 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial